Antiangiogenic drugs impede chemotherapy-stimulated tumor recovery

September 8, 2008

Scientists have gained new insight into a mechanism whereby chemotherapy may actually assist the rapid regrowth of tumors after treatment. The research, published by Cell Press in the September issue of the journal Cancer Cell, also helps to explain why a combination of traditional chemotherapy with drugs that block formation of new blood vessels might impede the devastating tumor recovery that often follows cancer therapy.

"Chemotherapy remains the most commonly employed form of systemic cancer treatment. However, although partial or complete shrinkage of tumor mass is frequently induced in chemotherapy-responsive tumors, survival benefits of such responses can be compromised by rapid regrowth of the drug-treated tumors," says senior study author Dr. Robert S. Kerbel from the University of Toronto.

Clinical trials have indicated that drugs that inhibit the growth of blood vessels, called antiangiogenic drugs, can sometimes enhance the effectiveness of traditional chemotherapy. For example, coadministration of the antiangiogenic drug bevacizumab with the chemotherapeutic agent paclitaxel improves survival benefits for metastatic breast cancer and small cell lung cancer. In contrast, coadministration of bevacizumab with gemcitabine for treatment of pancreatic cancer does not increase the effectiveness of chemotherapy alone.

"Several hypotheses have been proposed to explain how antiangiogenic drugs enhance the treatment efficacy of cytotoxic chemotherapy, including impairing the ability of chemotherapy-responsive tumors to regrow after therapy," says author Dr. Yuval Shaked. Drs. Kerbel, Shaked, and colleagues had previously shown that treatment with a type of cytotoxic-like agent known as a vascular disrupting agent (VDA) induces rapid mobilization of cells called circulating endothelial progenitors (CEPs) from the bone marrow compartment that helps the tumor to regrow blood vessels and thereby recover from treatment.

The researchers built on this earlier observation by analyzing whether different, conventional chemotherapeutic drugs had variable abilities to impact CEP mobilization and whether antiangiogenic drugs could block chemotherapy-induced CEP responses and hence amplify their effectiveness. They found that paclitaxel rapidly induced CEP mobilization whereas gemcitabine did not. They went on to show that pharmacological inhibition of CEP mobilization by combination treatment with an antiangiogenic drug or treatment of mutant mice deficient in CEPs resulted in enhanced antitumor effects mediated by paclitaxel but not gemcitabine.

"Our results provide a new perspective regarding the impact that conventional chemotherapy can have on tumor angiogenesis and hence how combination with antiangiogenic drugs may amplify the antitumor effects of chemotherapy," explains Dr. Kerbel. "Further, our findings provide a potential explanation of why not all chemotherapy drugs will necessarily have their efficacy enhanced by the addition of an antiangiogenic agent when the mechanism involves blunting CEP mobilization acutely induced by the chemotherapy drug."

Source: Cell Press

3.7 /5 (7 votes)  

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

gdpawel
Sep 09, 2008

Rank: not rated yet
In cancerous tissue, tumors cannot grow or spread (metastasize) without the development of new blood vessels. Blood vessels supply tissues with oxygen and nutrients necessary for survival and growth.

Endothelial cells, the cells that form the walls of blood vessels, are the source of new blood vessels and have a remarkable ability to divide and migrate. The creation of new blood vessels occurs by a series of sequential steps. An endothelial cell forming the wall of an existing small blood vessel (capillary) becomes activated, secretes enzymes that degrade the extracellular matrix (the spaces between the cells), invades the matrix, and begins dividing. Eventually, strings of new endothelial cells organize into hollow tubes, creating new networks of blood vessels that make tissue growth and repair possible.

Most of the time endothelial cells lie dormant. But when needed, short bursts of blood vessel growth occur in localized parts of tissues. New capillary growth is tightly controlled by a finely tuned balance between factors that activate endothelial cell growth and those that inhibit it.

About 15 proteins are known to activate endothelial cell growth and movement. At a critical point in the growth of a tumor, the tumor sends out signals to the nearby endothelial cells to activate new blood vessel growth. Two endothelial growth factors, VEGF and basic fibroblast growth factor (bFGF), are expressed by many tumors and seem to be important in sustaining tumor growth.

It is generally true that tumors with higher densities of blood vessels are more likely to metastasize and are correlated with poorer clinical outcomes. Also, the shedding of cells from the primary tumor begins only after the tumor has a full network of blood vessels. In addition, both angiogenesis and metastasis require matrix metalloproteinases, enzymes that break down the surrounding tissue (the extracellular matrix), during blood vessel and tumor invasion.

Research has shown that controlling production of new blood vessels can restrict tumor growth, often prolonging the life of the cancer patient. Perhaps the most widely-used anti-angiogenic agent to emerge to date has been the drug Avastin. It is increasingly being realized that circulating microvascular cells may be important markers for a wide variety of cancers.

Avastin works by choking off the blood vessels that provide a tumor with oxygen and nutrients (angiogenesis). Angiogenesis starts when cancer cells produce a variety of growth factors and other activators (biologic molecules that begin a process). Growth factors cause endothelial cells to produce chemicals that break down the nearby tissue and the extracellular matrix. Then, the endothelial cells divide into more cells and begin building new blood vessels. Other elements, such as stromal cells (cells that form connective tissue), provide structural support for the new blood vessels.

The assumption is that if a drug can stop the tumor from receiving the supply of nutrients, the tumor will "starve" and die. However, there are so many agents out there now, doctors have a confusing array of choices. They don't know how to mix them together in the right order.
Rank 3.7 /5 (7 votes)
Relevant PhysicsForums posts
  • Is Everyday Technology Killing Us?
    createdFeb 08, 2012
  • Exercise and weight loss
    createdFeb 08, 2012
  • Why do we have head aches? Our brains can't feel anything.
    createdFeb 07, 2012
  • "The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
    createdFeb 04, 2012
  • Oncolytic adenovirus
    createdFeb 04, 2012
  • Nutrition label stuffs and diets
    createdFeb 02, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Tenofovir, leading HIV medication, linked with risk of kidney damage

(Medical Xpress) -- Tenofovir, one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, is associated with a significant risk of kidney damage and chronic kidney disease that increases over ...

Medicine & Health / Medications

created 13 minutes ago | popularity not rated yet | comments 0 | with audio podcast

Georgia Tech develops software for the rapid analysis of foodborne pathogens

2011 brought two of the deadliest bacterial outbreaks the world has seen during the last 25 years. The two epidemics accounted for more than 4,200 cases of infectious disease and 80 deaths. Software developed at Georgia Tech ...

Medicine & Health / Diseases

created 1 hour ago | popularity not rated yet | comments 0

Can Viagra treat childhood lymphatic disorder?

(Medical Xpress) -- A surprising potential therapy for severe, hard-to-treat malformations of the lymphatic system is now being studied at the Stanford School of Medicine and Lucile Packard Children’s Hospital: researchers ...

Medicine & Health / Diseases

created 47 minutes ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

Don't ignore kids' snores

(Medical Xpress) -- Your ears aren’t playing tricks on you – that is the sound of snoring you hear from the bedroom of your preschooler. Snoring is common in children, but in some cases it can be a symptom of a ...

Medicine & Health / Diseases

created 37 minutes ago | popularity not rated yet | comments 0

WHO calls for stepped-up fight against leprosy

The World Health Organization called Monday for greater efforts to fight leprosy, warning the disfiguring disease was defying efforts to wipe it out across many countries in the Asia-Pacific region.

Medicine & Health / Diseases

created 43 minutes ago | popularity not rated yet | comments 0


With climate change, today's '100-year floods' may happen every three to 20 years: research

Last August, Hurricane Irene spun through the Caribbean and parts of the eastern United States, leaving widespread wreckage in its wake. The Category 3 storm whipped up water levels, generating storm surges ...

Researchers make better heat sensor based on butterfly wings

(PhysOrg.com) -- Scientists have long known that butterfly wings produce their iridescent colors by bouncing light around and between tiny ridges in structures made of chitin. More recently they’ve discovered ...

Manipulating genes with hidden TALENs

(PhysOrg.com) -- A better understanding of gene function in model plant and animal systems could be used to develop useful traits in livestock and crop plants, and might someday lead to developments in stem ...

Alien matter in the solar system: A galactic mismatch

This just in: The Solar System is different from the space just outside it.

Couples in the same place emotionally stay together, study says

(Medical Xpress) -- Despite life’s ups and downs, couples whose feelings are in sync consistently over time are more likely to stay together, says a University of California, Davis, study.

NDSU nano research could impact flexible electronic devices

A discovery by a research team at NDSU and the National Institute of Standards and Technology shows the flexibility and durability of carbon nanotube films and coatings are intimately linked to their electronic properties. ...